BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9241096)

  • 1. The comparison of the responsiveness of human isolated internal mammary and gastroepiploic arteries to levcromakalim: an alternative approach to the management of graft spasm.
    Akar F; Uydeş-Dogan BS; Tufan H; Aşlamaci S; Köksoy C; Kanzik I
    Br J Clin Pharmacol; 1997 Jul; 44(1):49-56. PubMed ID: 9241096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxant effect of levcromakalim in isolated human small subcutaneous arteries.
    Hüsken BC; Vroom MB; Timmenga EJ; Pfaffendorf M; Van Zwieten PA
    Eur J Pharmacol; 1995 Dec; 287(3):313-6. PubMed ID: 8991807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasorelaxant actions of enoximone, dobutamine, and the combination on human arterial coronary bypass grafts.
    Cracowski JL; Stanke-Labesque F; Chavanon O; Blin D; Mallion JM; Bessard G; Devillier P
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):741-8. PubMed ID: 10547092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T; Angus JA
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the nature of vasoconstriction in arterial grafts for coronary operations.
    He GW; Yang CQ; Starr A
    Ann Thorac Surg; 1995 Mar; 59(3):676-83. PubMed ID: 7887711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glibenclamide inhibits hypoxic relaxation of isolated porcine coronary arteries under conditions of impaired glycolysis.
    Mellemkjaer S; Nielsen-Kudsk JE
    Eur J Pharmacol; 1994 Aug; 270(4):307-12. PubMed ID: 7805779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of vasodilator effects of the potassium channel openers NIP-121 and levcromakalim in dogs and rats.
    Yamashita T; Masuda Y; Kawamura N; Fujikura N; Tanaka S
    Jpn J Pharmacol; 1995 Jun; 68(2):145-52. PubMed ID: 7563971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery.
    He GW; Yang CQ
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):13-9. PubMed ID: 7564353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K; Yamada H; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro hypoxia on rat pulmonary artery: effects on contractions to spasmogens and role of KATP channels.
    Wanstall JC; O'Brien E
    Eur J Pharmacol; 1996 May; 303(1-2):71-8. PubMed ID: 8804913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional comparison between the human inferior epigastric artery and internal mammary artery. Similarities and differences.
    He GW; Acuff TE; Ryan WH; Yang CQ; Mack MJ
    J Thorac Cardiovasc Surg; 1995 Jan; 109(1):13-20. PubMed ID: 7815788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts.
    Liu MH; Floten SH; Yang Q; He GW
    Br J Clin Pharmacol; 2001 Sep; 52(3):279-87. PubMed ID: 11560560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of nisoldipine and nitroglycerin on human internal mammary artery.
    Liu JJ; Johnston CI; Buxton BF
    J Pharmacol Exp Ther; 1994 Jan; 268(1):434-40. PubMed ID: 8301585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts.
    He GW; Yang CQ
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):208-14. PubMed ID: 8856475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.
    Iwamoto T; Nishimura N; Morita T; Sukamoto T
    J Pharm Pharmacol; 1993 Apr; 45(4):292-7. PubMed ID: 8098370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thromboxane A2 and K(ATP) channel antagonist actions of a series of sulphonylurea derivatives in the pig coronary artery.
    McPherson GA; Choi RT; Kong DC; Iskander MN
    Eur J Pharmacol; 1997 Apr; 324(2-3):193-200. PubMed ID: 9145771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vasoconstriction by potassium channel opener aprikalim in human conduit arteries used as bypass grafts.
    He GW; Yang CQ
    Br J Clin Pharmacol; 1997 Oct; 44(4):353-9. PubMed ID: 9354310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of quaternary ion antagonism of levcromakalim-induced relaxation in pig coronary artery.
    Piekarska AE; McPherson GA
    Eur J Pharmacol; 1997 Mar; 322(1):37-44. PubMed ID: 9088868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater contractility of internal mammary artery bifurcation: possible cause of low patency rates.
    He GW; Ryan WH; Acuff TE; Yang CQ; Mack MJ
    Ann Thorac Surg; 1994 Aug; 58(2):529-32. PubMed ID: 8067857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane receptor stimulation suppresses guanylate cyclase-mediated relaxation of radial arteries.
    Arshad M; Vijay V; Floyd BC; Marks B; Sarabu MR; Wolin MS; Gupte SA
    Ann Thorac Surg; 2006 Jun; 81(6):2147-54. PubMed ID: 16731144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.